PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24508089-3	2014	The synthesized graft copolymer (Ag-g-PAM) has been investigated (in vitro) for controlled and colon targeted release of 5-amino salicylic acid (5-ASA).	copolymer	22-31	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	38-41	
27474601-4	2016	The factors affecting the intrinsic viscosity and the yield of copolymer were studied, which showed that the optimum conditions for the synthesis of NCS-g-PAM were mAM:mNCS=8:1, 0.15g of initiator dosage, mCS:mTPP=4.5:1, 1min of ultrasonication time, 4h of illumination time, and 30min of stirring time.	copolymer	63-72	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	155-158	
18452324-1	2008	The salt effect on the complex formation of poly(acrylamide)- block-poly(sodium acrylate) (PAM- b-PAA) as a neutral-anionic block copolymer and dodecyltrimethylammonium bromide (DTAB) as a cationic surfactant at different NaBr concentrations, CNaBr, was investigated by turbidimetric titration, steady-state fluorescence spectroscopy, and dynamic light scattering.	copolymer	130-139	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	91-94	
23732799-2	2013	The graft copolymer was developed by grafting PAM chains onto HPMC backbone using potassium persulphate as initiator.	copolymer	10-19	peptidylglycine alpha-amidating monooxygenase	Homo sapiens	46-49